Pneumococcal Vaccination in Immunocompromised Hosts: An Update

Infections with the pathogen, Streptococcus pneumoniae, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination s...

Descripción completa

Detalles Bibliográficos
Autores principales: Froneman, Claire, Kelleher, Peter, José, Ricardo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223771/
https://www.ncbi.nlm.nih.gov/pubmed/34063785
http://dx.doi.org/10.3390/vaccines9060536
_version_ 1783711758529069056
author Froneman, Claire
Kelleher, Peter
José, Ricardo J.
author_facet Froneman, Claire
Kelleher, Peter
José, Ricardo J.
author_sort Froneman, Claire
collection PubMed
description Infections with the pathogen, Streptococcus pneumoniae, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination should be offered. Here, we discuss the role of pneumococcal vaccination in specific groups of immunocompromised hosts.
format Online
Article
Text
id pubmed-8223771
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82237712021-06-25 Pneumococcal Vaccination in Immunocompromised Hosts: An Update Froneman, Claire Kelleher, Peter José, Ricardo J. Vaccines (Basel) Review Infections with the pathogen, Streptococcus pneumoniae, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination should be offered. Here, we discuss the role of pneumococcal vaccination in specific groups of immunocompromised hosts. MDPI 2021-05-21 /pmc/articles/PMC8223771/ /pubmed/34063785 http://dx.doi.org/10.3390/vaccines9060536 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Froneman, Claire
Kelleher, Peter
José, Ricardo J.
Pneumococcal Vaccination in Immunocompromised Hosts: An Update
title Pneumococcal Vaccination in Immunocompromised Hosts: An Update
title_full Pneumococcal Vaccination in Immunocompromised Hosts: An Update
title_fullStr Pneumococcal Vaccination in Immunocompromised Hosts: An Update
title_full_unstemmed Pneumococcal Vaccination in Immunocompromised Hosts: An Update
title_short Pneumococcal Vaccination in Immunocompromised Hosts: An Update
title_sort pneumococcal vaccination in immunocompromised hosts: an update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223771/
https://www.ncbi.nlm.nih.gov/pubmed/34063785
http://dx.doi.org/10.3390/vaccines9060536
work_keys_str_mv AT fronemanclaire pneumococcalvaccinationinimmunocompromisedhostsanupdate
AT kelleherpeter pneumococcalvaccinationinimmunocompromisedhostsanupdate
AT josericardoj pneumococcalvaccinationinimmunocompromisedhostsanupdate

Ejemplares similares